APA (7th ed.) Citation

Müller, A. R., Zinkstok, J. R., Rommelse, N. N. J., van de Ven, P. M., Roes, K. C. B., Wijburg, F. A., . . . van Eeghen, A. M. (2021). Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: Protocol for a series of N-of-1 trials. Orphanet Journal of Rare Diseases, 16(1), 1. https://doi.org/10.1186/s13023-021-02003-z

Chicago Style (17th ed.) Citation

Müller, A. R., et al. "Methylphenidate for Attention-deficit/hyperactivity Disorder in Patients with Smith-Magenis Syndrome: Protocol for a Series of N-of-1 Trials." Orphanet Journal of Rare Diseases 16, no. 1 (2021): 1. https://doi.org/10.1186/s13023-021-02003-z.

MLA (9th ed.) Citation

Müller, A. R., et al. "Methylphenidate for Attention-deficit/hyperactivity Disorder in Patients with Smith-Magenis Syndrome: Protocol for a Series of N-of-1 Trials." Orphanet Journal of Rare Diseases, vol. 16, no. 1, 2021, p. 1, https://doi.org/10.1186/s13023-021-02003-z.